Impact of Rash Development for Patients with Non-Small Cell Lung Cancer Receiving PD-1/PD-L1-Based Immune Checkpoint Inhibitor Therapy - Vienna 2024

Lung cancer with comorbidity- and risk factor-tinted spectacles

Chair(s): Armin Frille, Gianna Vargas Centanaro

Session type: Poster session

Impact of Rash Development for Patients with Non-Small Cell Lung Cancer Receiving PD-1/PD-L1-Based Immune Checkpoint Inhibitor Therapy

Yongsheng Yang

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Acceptance of illness in lung cancer patients during treatment: Do women differ from men?

Anna Trojnar

Poster

Abstract

COPD and pulmonary emphysema as prognostic factors in patients with non-small cell lung cancer receiving immunotherapy

Marcos Becerra Aineto

Poster

Abstract

Distinctive features of lung cancer in women

Mehdi Maaroufi

Abstract

Assessing causality between frailty and lung cancer: A bi-directional Mendelian randomization analysis

Chuangsen Fang

Poster

Abstract

Biofuel pollution: a risk factor for COPD and bronchogenic carcinoma

Fatima Ezzahra Haouassia

Poster

Abstract

Profiling of young patients with lung cancer: a retrospective 10-year analysis

Joana Da Silva Cruz Gameiro Duarte

Poster

Abstract

Efficacy of Immune Checkpoint Inhibitor on Non-Small Cell Lung Cancer with Chronic Obstructive Pulmonary Disease

Huohuo Zhang

Poster

Abstract

Association of interstitial lung abnormalities with overall survival in patients with lung cancer: a meta-analysis

Haoyu Wang

Poster

Abstract

THE IMPACT OF CONTROLLING NUTRITIONAL STATUS (CONUT) IN THE PROGNOSIS OF NON-SMALL CELL LUNG CANCER

Raffaella Pagliaro

Poster

Abstract

COPD as a comorbidity in lung cancer

Pontus Mertsch

Abstract

Impact of Rash Development for Patients with Non-Small Cell Lung Cancer Receiving PD-1/PD-L1-Based Immune Checkpoint Inhibitor Therapy

Yongsheng Yang

Abstract

Impact of OLD/emphysema in LC mortality risk in screening programs: an analysis of NLST and P-IELCAP

Marcela Suarez

Abstract

Is duration of Chronic obstructive pulmonary disease risk factor decreasing survival rate in patients with lung cancer?

Robert Uli?ski

Poster

Abstract

Emphysema, COPD and smoking burden among lung cancer survivors with a second primary lung cancer compared with patients with just one primary lung cancer.

Matilde Sangro Prieto

Poster

Abstract

Impact of COPD on one-year survival of patients with advanced stage lung cancer- a prospective cohort study

Aswathy Girija

Abstract

Interstitial lung diseases with concomitant lung cancer: a data mining approach

Giulia Maria Stella

Poster

Abstract

Clinical trial interest from patients with COPD approached after Lung Cancer Screening

Tanya Patrick

Poster

Abstract

Nationwide Comorbidity Evaluation in Lung Cancer Patients Across a 40-Year Period

Morten Borg

Poster

Abstract

Late Breaking Abstract - Eligibility for lung cancer screening among incidental lung nodule patients in a major healthcare system

Matilde Sangro Prieto

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}